Hyderabad: As part of Quad Vaccination The partnership, the United States International Development Finance Corporation (DFC) will provide $50 million in financial assistance to Hyderabad-based Biological E Ltd to help the vaccine maker increase its capacity to manufacture more than 1 billion doses of Covid-19 vaccines. end of 2022.
DFC’s Chief Operating Officer David Marchik and Biological E’s Managing Director Mahima Datla will sign the dotted line of the agreement in Hyderabad on Monday.
The formalization of the financing agreement comes six months after the US government announced its decision to support the Indian vaccine maker. Tractor The Leaders Summit was held virtually in March 2021.
The Quad is an informal strategic forum comprising India, the US, Japan and Australia, aimed at countering China’s growing influence in the Indo-Pacific region.
Biological E has already been roped in by US pharma major Johnson & Johnson to make more than 500 million doses of its Covid-19 vaccine per year. J&J had entered into an agreement in August 2020 to manufacture single-shot Janssen Covid-19 vaccine doses in India.
Datala, managing director of organic e, had earlier told TOI that the Quad initiative would offer “broad support”. bio e To increase capacity” for both the J&J vaccine and is being developed in collaboration with Baylor College of Medicine, Houston, after receiving prior World Health Organization qualification.
DFC’s Chief Operating Officer David Marchik and Biological E’s Managing Director Mahima Datla will sign the dotted line of the agreement in Hyderabad on Monday.
The formalization of the financing agreement comes six months after the US government announced its decision to support the Indian vaccine maker. Tractor The Leaders Summit was held virtually in March 2021.
The Quad is an informal strategic forum comprising India, the US, Japan and Australia, aimed at countering China’s growing influence in the Indo-Pacific region.
Biological E has already been roped in by US pharma major Johnson & Johnson to make more than 500 million doses of its Covid-19 vaccine per year. J&J had entered into an agreement in August 2020 to manufacture single-shot Janssen Covid-19 vaccine doses in India.
Datala, managing director of organic e, had earlier told TOI that the Quad initiative would offer “broad support”. bio e To increase capacity” for both the J&J vaccine and is being developed in collaboration with Baylor College of Medicine, Houston, after receiving prior World Health Organization qualification.
.